47 reports

HIV/ AIDS Diagnostic Testing Market, 2021 I.

  • Ambulatory Care
  • Europe
  • France
  • Germany
  • Demand

The report provides the ##-year test volume and sales forecasts by country for HIV-##/ ##/ Combo, HIV Ag, HTLV-I/ II, Western Blot and other confirmatory tests performed in the following markets:- Hospitals - Public Health Labs - Commercial/ Private Labs - Blo

  • Ambulatory Care
  • HIV AIDS
  • Europe
  • Germany
  • Demand

This can be attributed to the high prevalence of diseases such as HIV/ AIDS, hepatitis, Ebola, caused by viral infections.

  • Ambulatory Care
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

CVDs account for highest patient pool in the country, after HIV/ AIDS.

  • Ambulatory Care
  • Cardiovascular Disease
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Teleflex Incorporated

Cardiovascular diseases accounts for highest patient pool in the country, after HIV/ AIDS.

  • Ambulatory Care
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Teleflex Incorporated

IT IS A CHRONIC, NON-COMMUNICABLE INFLAMMATORY DISEASE WHICH IS OFTEN MISTAKEN FOR CONTAGIOUS DISEASES, SUCH AS LEPROSY, SYPHILIS AND EVEN HIV/ AIDS.

  • Ambulatory Care
  • Market Size
  • Amgen Inc.
  • Samsung Bioepis Co., Ltd.
  • Sandoz Inc.

BMS DRUGS PORTFOLIO INCLUDE MEDICINES THAT TREAT CANCER, CARDIOVASCULAR DISEASE, HEPATITIS B AND HEPATITIS C, HIV/ AIDS, RHEUMATOID ARTHRITIS AND DERMATOLOGY.

  • Ambulatory Care
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.

Forward Pharma A/ S (Denmark) ##.

  • Ambulatory Care
  • World
  • Demand
  • Market Competition
  • Market Shares

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Ambulatory Care
  • Germany
  • Japan
  • United States
  • Forecast

He is experienced in designing and executing operational research study on HIV/ AIDS services uptake among high risk groups (HRGs) in India.

  • Ambulatory Care
  • Japan
  • Spain
  • United States
  • Forecast

The company offers active pharmaceutical ingredients and formulations in various therapeutic areas including women' s health, cardiovascular, children' s health, dermatology and cosmeceuticals, diabetes, HIV-AIDS, and hepatitis etc.

  • Ambulatory Care
  • India
  • Allergan plc
  • Cipla Ltd
  • Novartis AG

EngendaHealth is another US-based nonprofit organization that supports family planning, HIV/ AIDS and maternal healthcare in ## countries in the developing world and the United States.

  • Ambulatory Care
  • Clinic
  • Healthcare
  • United States
  • Forecast

It concentrates its R& D efforts in the area of diseases with significant unmet medical needs: HIV/ AIDS, oncology, hepatitis, immunologic disorders, and cardiovascular and fibrotic disease.

  • Ambulatory Care
  • Baxter International Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Spectrum Pharmaceuticals, Inc.

AIDS PATIENTS).

  • Ambulatory Care
  • North America
  • United States
  • Allergan plc
  • Neurotech Pharmaceuticals, Inc.

Vincent' s Hospital' s HIV/ AIDS Center ## Mount Sinai Medical Center Enters Into Research Collaboration With Isilon Systems ## Mount Sinai Forms Joint Venture With Columbia University ## Continuum Health Partners And Mount Sinai Medical Center Complete Merger ## Mou

  • Ambulatory Care
  • Health Services
  • United States
  • Deals & Alliance
  • M&A

Patients will subsequently be randomized ##:## at week ## to either continue administering Squalamine Eye Drops or discontinue drops for the remainder of the ##-week study.

  • Ambulatory Care
  • Pharmaceutical
  • United States
  • Product Initiative
  • Ohr Pharmaceutical Inc.

The molecules developed by companies in Phase III, Phase II, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Ambulatory Care
  • Eye Disease
  • United States
  • Product Initiative
  • Ohr Pharmaceutical Inc.
  • Pipeline by Benitec Biopharma Ltd, H1 2018
  • Pipeline by Alteogen Inc, H1 2018

The company also licenses its ddRNAi to various biopharmaceutical companies for the development of drugs for the treatment of conditions such as HIV/ AIDS, Huntingtons disease, chronic neuropathic pain, cancer immunotherapy and retinitis.

  • Ambulatory Care
  • Ophthalmology
  • Therapy
  • World
  • Regeneron Pharmaceuticals, Inc.
  • PIPELINE BY ALTEOGEN INC, H1 2018

The company also licenses its ddRNAi to various biopharmaceutical companies for the development of drugs for the treatment of conditions such as HIV/ AIDS, Huntington' s disease, chronic neuropathic pain, cancer immunotherapy and retinitis.

  • Ambulatory Care
  • United States
  • World
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

It develops gene-based drugs that cure liver cancer, HIV, AIDS, Parkinson' s disease, and diabetes.

  • Ambulatory Care
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • CONTEXT THERAPEUTICS ENTERS INTO PARTNERSHIP WITH CEDARS-SINAI MEDICAL CENTER, FRED HUTCHINSON CANCER RESEARCH CENTER AND SYNERGIE LYON CANCER

Fred Hutchinson Cancer Research Center (Fred Hutchinson), a subsidiary of National Comprehensive Cancer Network, is a nonprofit organization which conducts research on the prevention, diagnose and treatment of cancer, HIV/ AIDS and other life threatening diseases.

  • Ambulatory Care
  • Healthcare
  • Therapy
  • United States
  • Capricor Therapeutics, Inc.

" The new CFAR builds on Einstein and Montefiore' s longstanding achievements in HIV and AIDS research and our shared commitment to social justice, " says Dr.

  • Ambulatory Care
  • Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • CALYXT

The Global Gene Therapy Partnering Agreements 2010-2018 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...

  • Ambulatory Care
  • Gene Therapy
  • Therapy
  • United States
  • uniQure N.V.
  • OCT 2012

The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest joint...

  • Ambulatory Care
  • Biotech
  • Pharmaceutical
  • Deals & Alliance
  • Wildwood Ventures Limited

GOVERNMENT S INITIATIVE TO DELIVER LIFE-SAVING SERVICES AND IMPROVE THE LIVES OF THOSE LIVING WITH HIV/ AIDS AROUND THE WORLD.

  • Ambulatory Care
  • Clinical Trial
  • Medical Device
  • United States
  • Company

" By receiving this additional funding from the Ryan White HIV/ AIDS program, more children living with HIV in our state whose families have a difficult time affording medical care will receive comprehensive HIV/ AIDS care available at Connect

  • Ambulatory Care
  • Health Services
  • Healthcare
  • United States
  • Deals & Alliance

This has already been seen in HIV/ AIDS, and is likely to be replicated with NCDs. "

  • Ambulatory Care
  • Clinical Trial
  • Infectious Disease
  • United States
  • GlobalData's company

This has already been seen in HIV/ AIDS, and is likely to be replicated with NCDs. "

  • Ambulatory Care
  • Clinical Trial
  • Eyewear
  • Medical Device
  • GlobalData's company

This has already been seen in HIV/ AIDS, and is likely to be replicated with NCDs. "

  • Ambulatory Care
  • Clinical Trial
  • United States
  • Company
  • GlobalData's company

It develops gene-based drugs that cure liver cancer, HIV, AIDS, Parkinson' s disease, and diabetes.

  • Ambulatory Care
  • Health Services
  • Healthcare
  • Pharmaceutical
  • United States